University of Rochester NCORP Research Base

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Rochester NCORP Research Base sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 2 currently recruiting 4 completed later-stage tilt top decile by trial count

University of Rochester NCORP Research Base: 11 sponsored US clinical trials, 2 recruiting.

University of Rochester NCORP Research Base sponsors 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Malignant Solid Neoplasm, with 4 trials.

Top-decile sponsor footprint

University of Rochester NCORP Research Base ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

11 total, page 1 of 1

RECRUITING

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

NCT07638007
RECRUITING Phase 3

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

NCT04829539
ACTIVE NOT RECRUITING

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

NCT05364086
ACTIVE NOT RECRUITING NA

Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy

NCT04888988
ACTIVE NOT RECRUITING NA

Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers

NCT04062552
ACTIVE NOT RECRUITING Phase 3

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

NCT03996265
ACTIVE NOT RECRUITING

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

NCT01382082
COMPLETED NA

Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy

NCT04367480
COMPLETED Phase 3

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

NCT03367572
COMPLETED Phase 2

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

NCT03186638
COMPLETED NA

Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors

NCT02613364

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 3

Therapeutic Areas

Malignant Solid Neoplasm 4
Hematopoietic and Lymphoid Cell Neoplasm 3
Malignant Neoplasm 2
Cancer Survivor 1
Advanced Malignant Solid Neoplasm 1
Cognitive Impairment 1
Recurrent Malignant Solid Neoplasm 1
Chemotherapy-induced Peripheral Neuropathy 1
Hematopoietic and Lymphatic System Neoplasm 1
Breast Carcinoma 1

Where University of Rochester NCORP Research Base enrollment is open (later-stage tilt)

2 recruiting of 11 indexed (18% open); 4 completed (36%).

Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Malignant Solid Neoplasm (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Rochester NCORP Research Base: open-pipeline peers nationwide

Peers matched on 11 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University of Rochester NCORP Research Base sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10.910.91111.1 0%5%10%15%20% Total trials Recruiting share University of Rochester NCORP Research BaseAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeBurke Medical Research InstituteGrand Valley State UniversityImunonInventisBio Co.
University of Rochester NCORP Research Base sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Rochester NCORP Research Base sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Rochester NCORP Research Base page

11 registered trials is a research-attention snapshot, not an endorsement of University of Rochester NCORP Research Base or any single study.

  • 2 of University of Rochester NCORP Research Base's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Malignant Solid Neoplasm is the condition University of Rochester NCORP Research Base studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Malignant Solid Neoplasm trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Rochester NCORP Research Base pipeline card: 11 registered trials from official public datasets.Report a data error.